PMID: 11309439Apr 20, 2001Paper

Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management

Journal of the National Cancer Institute
M GrecoN Cascinelli

Abstract

Surgical removal of axillary lymph node and histologic examination for metastases are used to determine whether adjuvant treatment is necessary for patients with breast cancer. Axillary lymph node dissection (ALND) is a costly procedure associated with various side effects, and 80% or more of patients with tumors of 20 mm or less are lymph node negative and might avoid ALND. In this study, we evaluated whether an alternative, noninvasive method--i.e., positron emission tomography (PET) with 2-[(18)F]fluoro-2-deoxy-D-glucose (FDG)-- could be used to determine axillary lymph node status in patients with breast cancer. One hundred sixty-seven consecutive patients with breast cancers of 50 mm or less (range = 5-50 mm; mean = 21 mm) scheduled for complete ALND were studied preoperatively with FDG-PET, and then PET and pathology results from ALND were compared. All statistical tests were two-sided. The overall sensitivity, specificity, and accuracy of lymph node staging with PET were 94.4% (PET detected 68 of 72 patients with axillary involvement; 95% confidence interval [CI] = 86.0% to 98.2%), 86.3% (82 of 95 patients without axillary involvement; 95% CI = 77.8% to 91.9%), and 89.8% (150 of 167 patients with breast cancer; 95% CI = ...Continue Reading

References

Oct 1, 1994·British Journal of Cancer·S MénardM I Colnaghi
Sep 1, 1994·Annals of Surgery·A E GiulianoD L Morton
Jul 1, 1993·Journal of Computer Assisted Tomography·C K HohE Nitzsche
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B G HafftyM Reiss
Mar 12, 1998·World Journal of Surgery·D Y NohK J Choe
Mar 24, 1998·Journal of the American College of Surgeons·P J BorgsteinS Meijer
Apr 17, 1998·Journal of the American College of Surgeons·B J O'HeaH S Cody
Aug 15, 1998·Seminars in Nuclear Medicine·H N Wagner
Aug 15, 1998·Seminars in Nuclear Medicine·T F Budinger
Oct 1, 1998·The New England Journal of Medicine·D KragP Beitsch
Oct 1, 1998·The New England Journal of Medicine·K M McMastersM J Edwards
Nov 4, 1998·Seminars in Nuclear Medicine·F L FlanaganB A Siegel
Nov 17, 1998·American Journal of Surgery·H SniderD Oleske
Feb 6, 1999·European Journal of Nuclear Medicine·M R Keshtgar, P J Ell
Mar 2, 1999·Journal of the National Cancer Institute·U VeronesiD Scarpa
Apr 13, 1999·European Journal of Nuclear Medicine·O E NiewegB B Kroon
Apr 13, 1999·European Journal of Nuclear Medicine·E van der Wall

❮ Previous
Next ❯

Citations

Jan 14, 2004·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Tsuneo TamakiKatsuhiko Kawahara
Oct 25, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Tevfik F CermikAbass Alavi
Feb 5, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Marieke E StraverMarie-Jeanne T F D Vrancken Peeters
Aug 9, 2005·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·J Scott SlokaMaria Mathews
Dec 11, 2003·Current Oncology Reports·Michelle D McDonoughBetty A Mincey
Feb 24, 2012·Annals of Nuclear Medicine·Yasemin SanliAyse Mudun
Feb 9, 2012·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Bhumsuk KeamYung-Jue Bang
Jul 24, 2002·Seminars in Roentgenology·Farrokh Dehdashti, Barry A Siegel
Mar 31, 2007·The Lancet Oncology·John R BensonUNKNOWN Axilla Management Consensus Group
Jan 1, 2003·Acta medica Austriaca·J Czernin
Oct 24, 2001·Current Opinion in Oncology·A C Wolff
Jun 29, 2002·Nuclear Medicine Communications·C RoséN Avril
Feb 16, 2006·Nuclear Medicine Communications·Rakesh KumarAbass Alavi
Feb 6, 2008·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·K Planche, S Vinnicombe
Oct 9, 2007·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Conor D Collins
Mar 18, 2003·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Lale KostakogluStanley J Goldsmith
Jul 1, 2005·Breast Cancer Research : BCR·François Bénard, Eric Turcotte
Jan 7, 2003·Annals of Surgical Oncology·Edward A LevineLee P Adler
Aug 18, 2004·Annals of Surgical Oncology·Elisa R Port, Hiram S Cody
Mar 17, 2010·Annals of Surgical Oncology·Alice Chung, Armando Giuliano
Sep 19, 2012·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Anusheel MunshiUNKNOWN other Locoregional Panel Members
Oct 18, 2007·Radiology·Daniel J A MargolisSanjiv S Gambhir
Jan 27, 2007·Radiology·Todd M BlodgettDavid W Townsend
Feb 7, 2008·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Hyo Soon LimJung Han Yoon
Oct 17, 2002·The British Journal of Radiology·A RieberT Kuehn
Mar 27, 2004·Radiology·Eric M RohrenR Edward Coleman
Apr 28, 2004·Journal of General Internal Medicine·Anthony J AlbergMarie Diener-West

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.